Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome
Iron chelation therapy is often used to treat iron overload in patients requiring transfusion of red blood cells (RBC). A 76-year-old man with MDS type refractory cytopenia with multilineage dysplasia, intermediate-1 IPSS risk, was referred when he became transfusion dependent. He declined infusion...
Saved in:
Main Authors: | Maha A. Badawi, Linda M. Vickars, Jocelyn M. Chase, Heather A. Leitch |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2010/164045 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Durable Red Blood Cell Transfusion Independence in a Patient with an MDS/MPN Overlap Syndrome Following Discontinuation of Iron Chelation Therapy
by: Harpreet Kochhar, et al.
Published: (2015-01-01) -
Iron Chelation Therapy in Myelodysplastic Syndromes
by: Emanuela Messa, et al.
Published: (2010-01-01) -
Myelodysplastic Syndrome with Transfusion Dependence Treated with Venetoclax
by: Waqas Jehangir, et al.
Published: (2020-01-01) -
Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes
by: Ioannis Koutsavlis
Published: (2016-01-01) -
Higher Risk Myelodysplastic Syndromes in Patients with Well-Controlled HIV Infection: Clinical Features, Treatment, and Outcome
by: Bradley T. Williamson, et al.
Published: (2016-01-01)